Monday, November 22, 2021 1:11:38 PM
AIA- The Patent Trial and Appeal Board (PTAB) is a tribunal within the United States Patent and Trademark Office (USPTO) that reviews rejections made by examiners in proceedings called ex parte appeals and decides patentability questions for issued patents raised by third parties in proceedings called AIA trials.
The America Invents Act (AIA) created the PTAB or the Board. It was known previously as the Board of Patent Appeals and Interferences or BPAI. https://www.uspto.gov/patents/ptab/ptab-inventors
PTAB- The AIA trial proceedings were intended to be an alternative to district court litigation with several key differences from district court proceedings. For instance, AIA trials are conducted before a panel of three technically-trained administrative patent judges whereas district court litigation may be in front of a jury. Also, while discovery is available in both forums, discovery before the PTAB is more limited in scope, thereby costing the parties less to litigate. Finally, PTAB trials conclude normally within 12 months from institution; district court litigation, in contrast, may take several years to conclude. https://www.uspto.gov/learning-and-resources/newsletter/inventors-eye/patent-trial-and-appeal-board-who-are-they-and-what
PTAB (consequences)- In patent litigation, it is now essentially the norm for accused infringers to file a parallel IPR petition challenging patent validity and seek a stay of the district court litigation. In fact, IPR petitions have risen so dramatically over the last few years that the number of PTAB appeals before the federal circuit has recently eclipsed the number of district court patent appeals.
Given the pervasive use of AIA Petitions and the rate at which patents are being invalidated by the PTAB, it is not surprising that considerable disagreement exists on whether these new PTAB proceedings have improved or harmed the patent system overall. Many technology companies view IPRs and CBM reviews as a very effective way to challenge suspect patents and combat frivolous infringement litigation. However, numerous patent owners in the life science industries see the high invalidity rate of PTAB proceedings as an alarming trend that has decimated the ability to enforce U.S. patents and weakened America’s innovation system.
https://morningconsult.com/opinions/four-reasons-trumps-pick-next-uspto-director-matters/
JMO- The AIA approached solving the problem from the wrong end. Instead of making the USPTO more top heavy they should have raised the bar at the examiner level.
Now the PTAB has just become, in part, another stall tactic for big business.
Recent NLST News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 09:00:10 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/15/2024 04:15:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 09:00:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/12/2024 01:37:30 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/07/2024 08:02:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 01:00:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 03:00:12 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/24/2024 08:59:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2024 01:30:36 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/15/2024 02:32:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 09:00:29 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/28/2024 08:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 07:01:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 07:00:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:32:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:31:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:15 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 09:54:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 02:44:15 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/01/2024 09:35:01 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/01/2024 09:32:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:15:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 02:38:35 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM